210 related articles for article (PubMed ID: 19093182)
21. [Preoperative combination chemotherapy with TS-1 is effective in a case gastric cancer with peritoneal dissemination].
Nakamura R; Saikawa Y; Kubota T; Nakamura T; Akatsu Y; Takahashi T; Yoshida M; Otani Y; Kumai K; Kitajima M
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1323-6. PubMed ID: 16184933
[TBL] [Abstract][Full Text] [Related]
22. A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer.
Nakayama N; Ishido K; Chin K; Nishimura K; Azuma M; Matsusaka S; Inokuchi Y; Tanabe S; Kumekawa Y; Koizumi W
Gastric Cancer; 2017 Mar; 20(2):350-357. PubMed ID: 27189323
[TBL] [Abstract][Full Text] [Related]
23. Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis.
Satoi S; Fujii T; Yanagimoto H; Motoi F; Kurata M; Takahara N; Yamada S; Yamamoto T; Mizuma M; Honda G; Isayama H; Unno M; Kodera Y; Ishigami H; Kon M
Ann Surg; 2017 Feb; 265(2):397-401. PubMed ID: 28059968
[TBL] [Abstract][Full Text] [Related]
24. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Yamamoto K; Moon JH; Mori M; Doki Y
Anticancer Res; 2010 Apr; 30(4):1335-9. PubMed ID: 20530449
[TBL] [Abstract][Full Text] [Related]
25. A patient with gastric cancer with peritoneal carcinomatosis treated with intraperitoneal chemotherapy who survived more than 5 years receiving repeated laparoscopic examinations: a case report.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Nishikawa T; Tanaka J; Tanaka T; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Ishihara S; Sunami E; Watanabe T
J Med Case Rep; 2016 Jan; 10():14. PubMed ID: 26786355
[TBL] [Abstract][Full Text] [Related]
26. [A case of gastric cancer with peritoneal dissemination which has been alive more than three years responding to intraperitoneal chemotherapy].
Asami S; Idani H; Kubo S; Sasaki H; Kurose Y; Nojima H; Yoshioka T; Muro M; Kumano K; Hirata M; Yamashita T; Kin H; Takakura N
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2287-9. PubMed ID: 20037398
[TBL] [Abstract][Full Text] [Related]
27. The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
Sasaki K; Natsugoe S; Aridome K; Ishigami S; Hokita S; Aikou T
Hepatogastroenterology; 2007 Dec; 54(80):2421-4. PubMed ID: 18265679
[TBL] [Abstract][Full Text] [Related]
28. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
29. [Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401)].
Kimura Y; Machida H; Fujitani K; Yamamoto M; Tominaga K; Yano H; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Gan To Kagaku Ryoho; 2010 Jan; 37(1):151-5. PubMed ID: 20087052
[TBL] [Abstract][Full Text] [Related]
30. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated over 1 year 8 months with combined chemotherapy of paclitaxel and TS-1].
Tamura S; Miki H; Nakata K; Kim C; Takiuchi D; Okada K; Okamura S; Aihara T; Sugimoto K; Ohzato H; Tomita N; Takatsuka Y
Gan To Kagaku Ryoho; 2006 Feb; 33(2):255-7. PubMed ID: 16484868
[TBL] [Abstract][Full Text] [Related]
31. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
32. [Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination].
Sasaki K; Fujiwara Y; Kishi K; Motoori M; Sugimura K; Miyoshi N; Akita H; Gotoh K; Takahashi H; Marubashi S; Noura S; Ohue M; Yano M; Sakon M; Ishigami H; Kitayama J
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2319-21. PubMed ID: 24394098
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis.
Imano M; Yasuda A; Itoh T; Satou T; Peng YF; Kato H; Shinkai M; Tsubaki M; Chiba Y; Yasuda T; Imamoto H; Nishida S; Takeyama Y; Okuno K; Furukawa H; Shiozaki H
J Gastrointest Surg; 2012 Dec; 16(12):2190-6. PubMed ID: 23099736
[TBL] [Abstract][Full Text] [Related]
34. [A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
Iwai N; Wakabayashi N; Matsumoto N; Morita Y; Tanaka N; Yoriki H; Fujii K; Takada R; Takaya H; Masuzawa A; Takami S; Kataoka K
Gan To Kagaku Ryoho; 2015 Mar; 42(3):351-4. PubMed ID: 25812506
[TBL] [Abstract][Full Text] [Related]
35. [A case of highly advanced gastric cancer with peritoneal dissemination -- a histological CR to S-1 and CDDP combination chemotherapy].
Ito Y; Kurahashi S; Ito S; Misawa K; Niwa Y; Yatabe Y; Shimizu Y
Gan To Kagaku Ryoho; 2015 Mar; 42(3):355-8. PubMed ID: 25812507
[TBL] [Abstract][Full Text] [Related]
36. [A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy].
Nishiura H; Ishii K; Nonami M; Shigemori M; Katsurada A; Azechi H; Kondo M; Tojo M; Nishikawa K; Asagoe K; Otani Y; Inoue F; Suwa H; Saiga T
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2057-60. PubMed ID: 17197753
[TBL] [Abstract][Full Text] [Related]
37. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
Ishigami H; Kitayama J; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Hidemura A; Kaisaki S; Nagawa H
Oncology; 2009; 76(5):311-4. PubMed ID: 19299904
[TBL] [Abstract][Full Text] [Related]
38. [A case of advanced gastric cancer with peritoneal dissemination responding to S-1/CDDP neoadjuvant chemotherapy].
Mizutani S; Oyama T; Uchikoshi F; Yoshidome K; Tori M; Ueshima S; Hiraoka K; Yamagami Y; Takahashi H; Nakahara M
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1853-6. PubMed ID: 18030023
[TBL] [Abstract][Full Text] [Related]
39. [A case of gastric cancer with peritoneal dissemination successfully treated by S-1/paclitaxel combination chemotherapy].
Shoji T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):297-300. PubMed ID: 21368499
[TBL] [Abstract][Full Text] [Related]
40. [Strategy of treatment for gastric cancer with peritoneal metastasis].
Tanemura H; Oshita H; Yamada M; Hatoh T; Adachi T; Matsui K
Gan To Kagaku Ryoho; 2010 Mar; 37(3):443-6. PubMed ID: 20332680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
